The FDA Just Approved a New Topical Treatment for Sweating

Posted By American Med Spa Association, Monday, July 2, 2018

Today, the FDA approved a new treatment, Qbrexza cloth, for extreme underarm sweating, aka primary axillary hyperhidrosis, in adults and children ages nine and older. Nearly 10 million Americans suffer from hyperhidrosis.

The prescription topical wipe, which is applied directly to the skin (only the underarm area), works by inhibiting the activation of the sweat glands, therefore limiting the production of sweat. Packaged as single-use pre-moistened cloths, the medicine should be applied every 24 hours to clean, dry, unbroken skin. Immediately after using Qbrexza, it is important to thoroughly wash the hands—if the medicine is still on the hands and the eyes are touched, blurred vision can result.
Read more at New Beauty >>